"Peptide" has become one of the biggest marketing words in fitness and longevity right now. The problem: it's covering things that have almost nothing in common except molecular structure. An FDA-approved drug backed by tens of thousands of clinical trial participants gets the same word as a compound that's never been tested in a single completed human trial.

Let's actually separate them.

Semaglutide and tirzepatide (Ozempic, Wegovy, Mounjaro, Zepbound), this is the real deal: multi-phase FDA-approved drugs, tested in trials with thousands of participants each. Tirzepatide beat semaglutide by roughly 47% more weight loss in a head-to-head trial. The effect is real and well-documented.

The part that actually matters for anyone on these drugs: emerging 2026 data shows a real risk of losing lean muscle mass disproportionately to fat, especially with tirzepatide, during rapid weight loss. That's not a reason to avoid the drug, it's a reason to treat protein intake and resistance training as mandatory, not optional, while on it.

BPC-157 sold everywhere as a recovery peptide. The animal data is genuinely extensive: 100+ studies. The human data is almost nonexistent: as of 2026, only around 3 small pilot studies exist, fewer than 30 human subjects total, and zero placebo-controlled trials. A 42-person Phase 1 safety trial was quietly cancelled in 2016 and its results were never published, meaning the basic human dosing data everyone's current use is based on was extrapolated from rats, not measured in people.

TB-500 the sibling compound, usually stacked with BPC-157. It has even less human evidence: zero completed human efficacy trials, period. And here's the detail that should give anyone pause, a 2024 study found that the actual fragment being sold and injected as "TB-500" didn't accelerate healing at all. Only a metabolite of it did. People may be paying for and injecting a molecule that isn't even the biologically active one.

Both BPC-157 and TB-500 are, right now, in the middle of an actual regulatory decision, the FDA is reviewing both for a compounding pathway on July 23–24, 2026. That's not settled history, that's live.

GHK-Cu different story entirely. As a topical, it has decades of legitimate research behind it and is a genuinely well-evidenced cosmetic ingredient. What's changed is that people are now injecting it, the so-called "glow stack", which throws out 50 years of topical safety data and replaces it with essentially none, because nobody has studied what happens when you inject it instead of applying it to skin.

The takeaway isn't "peptides bad" or "peptides good." It's that the word is being used to borrow credibility that most of these compounds haven't earned yet. One of these four is thoroughly proven. Two have barely been tested in humans at all. One is well-proven for one use and completely untested for another. Know which one you're talking about before you decide what to think about it.

P.S. If you want this stuff applied to your actual body, goals, and training, not just a newsletter thought experiment, I'm opening up 3 coaching spots starting in October. That means a custom strength, nutrition, and supplement plan built around your schedule, your training, and your goals.

Apply for a spot →​APPLY HERE!!​